Gene therapy provides long-term visual function in a pre-clinical model of retinitis pigmentosa
Retinitis pigmentosa (RP) is a photoreceptor neurodegenerative disease. Patients with RP present with the loss of their peripheral visual field, and the disease will progress until there is a full loss of vision. Approximately 36,000 cases of simplex and familial RP worldwide are caused by a mutatio...
| Main Author: | |
|---|---|
| Language: | English |
| Published: |
2013
|
| Subjects: | |
| Online Access: | https://doi.org/10.7916/D8JS9XST |